Effective treatment of severe acute pancreatitis and COVID-19 pneumonia with tocilizumab
Effective treatment of severe acute pancreatitis and COVID-19 pneumonia with tocilizumab is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Effective treatment of severe acute pancreatitis and COVID-19 pneumonia with tocilizumab have?
Effective treatment of severe acute pancreatitis and COVID-19 pneumonia with tocilizumab has 11 citations in the OpenAlex counts ScholarIQ stores.
When was Effective treatment of severe acute pancreatitis and COVID-19 pneumonia with tocilizumab published?
Effective treatment of severe acute pancreatitis and COVID-19 pneumonia with tocilizumab has 2020 year in the ScholarIQ index.
What is the open-access status of Effective treatment of severe acute pancreatitis and COVID-19 pneumonia with tocilizumab?
Effective treatment of severe acute pancreatitis and COVID-19 pneumonia with tocilizumab has gold oa status in the ScholarIQ index.
What is the DOI of Effective treatment of severe acute pancreatitis and COVID-19 pneumonia with tocilizumab?
The DOI for Effective treatment of severe acute pancreatitis and COVID-19 pneumonia with tocilizumab is on the source record.
What is the PMID of Effective treatment of severe acute pancreatitis and COVID-19 pneumonia with tocilizumab?
The PMID for Effective treatment of severe acute pancreatitis and COVID-19 pneumonia with tocilizumab is on the source record.
What is the OpenAlex record for Effective treatment of severe acute pancreatitis and COVID-19 pneumonia with tocilizumab?
The OpenAlex for Effective treatment of severe acute pancreatitis and COVID-19 pneumonia with tocilizumab is on the source record.